Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.
J Eur Acad Dermatol Venereol
; 31(2): e73-e74, 2017 Feb.
Article
in En
| MEDLINE
| ID: mdl-27256718
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Lysis Syndrome
/
Melanoma
/
Antibodies, Monoclonal
Type of study:
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Year:
2017
Document type:
Article